Search Results - "Knatterud, GL"

Job and Industry Classifications Associated With Sarcoidosis in a Case-Control Etiologic Study of Sarcoidosis (ACCESS) by Barnard, Juliana, Rose, Cecile, Newman, Lee, Canner, Martha, Martyny, John, McCammon, Chuck, Bresnitz, Eddy, Rossman, Milt, Thompson, Bruce, Rybicki, Benjamin, Weinberger, Steven E., Moller, David R., McLennan, Geoffrey, Hunninghake, Gary, DePalo, Louis, Baughman, Robert P., Iannuzzi, Michael C., Judson, Marc A., Knatterud, Genell L., Teirstein, Alvin S., Yeager, Henry, Johns, Carol J., Rabin, David L., Cherniack, Reuben

“…Objective: To determine whether specific occupations and industries may be associated with sarcoidosis. Methods: A Case Control Etiologic. Study of Sarcoidosis…”
Get full text

Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study by Roberts, R, Rogers, W J, Mueller, H S, Lambrew, C T, Diver, D J, Smith, H C, Willerson, J T, Knatterud, G L, Forman, S, Passamani, E

“…In the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial, patients received intravenous recombinant tissue-type plasminogen activator (rt-PA) and…”
Get full text

Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial by Gore, J M, Sloan, M, Price, T R, Randall, A M, Bovill, E, Collen, D, Forman, S, Knatterud, G L, Sopko, G, Terrin, M L

“…In the Thrombolysis in Myocardial Infarction, Phase II pilot and clinical trial, 908 patients [326 (35.9%) in the pilot study and 582 (64.0%) in the randomized…”
Get full text

Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience by Sloan, M A, Price, T R, Petito, C K, Randall, A M, Solomon, R E, Terrin, M L, Gore, J, Collen, D, Kleiman, N, Feit, F

“…Parenchymatous intracerebral hemorrhage (ICH) is a serious, infrequent complication of thrombolytic therapy for acute myocardial infarction. We studied the…”
Get full text

Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator : results of the thrombolysis in myocardial infarction (TIMI) phase II-A trial by ROGERS, W. J, BAIM, D. S, ZARET, B. L, ROBERTSON, T. L, PASSAMANI, E. R, ROSS, R, KNATTERUD, G. L, BRAUNWALD, E, GORE, J. M, BROWN, B. G, ROBERTS, R, WILLIAMS, D. O, CHESEBRO, J. H, BABB, J. D, SHEEHAN, F. H, WACKERS, F. J. T

“…To assess the value and timing of percutaneous transluminal coronary angioplasty (PTCA) after thrombolytic therapy for acute myocardial infarction (AMI), 586…”
Get full text

A Case Control Etiologic Study of Sarcoidosis: Environmental and Occupational Risk Factors by Newman, Lee S, Rose, Cecile S, Bresnitz, Eddy A, Rossman, Milton D, Barnard, Juliana, Frederick, Margaret, Terrin, Michael L, Weinberger, Steven E, Moller, David R, McLennan, Geoffrey, Hunninghake, Gary, DePalo, Louis, Baughman, Robert P, Iannuzzi, Michael C, Judson, Marc A, Knatterud, Genell L, Thompson, Bruce W, Teirstein, Alvin S, Yeager, Henry, Jr, Johns, Carol J, Rabin, David L, Rybicki, Benjamin A, Cherniack, Reuben, ACCESS Research Group

“…Past research suggests that environmental factors may be associated with sarcoidosis risk. We conducted a case control study to test a priori hypotheses that…”
Get full text

Hemorrhagic Events During Therapy With Recombinant Tissue Plasminogen Activator, Heparin, and Aspirin for Unstable Angina (Thrombolysis In Myocardial Ischemia, Phase IIIB Trial) by Bovill, Edwin G, Tracy, Russell P, Knatterud, Genell L, Stone, Peter H, Nasmith, Jim, Gore, Joel M, Thompson, Bruce W, Tofler, Geoffrey H, Kleiman, Neal S, Cannon, Christopher, Braunwald, Eugene

“…This study assesses the effects of invasive procedures, hemostatic and clinical variables, and doses of recombinant tissue plasminogen activator (t-PA) on…”
Get full text

Evidence-based behavioral medicine: what is it and how do we achieve it? by Davidson, Karina W, Goldstein, Michael, Kaplan, Robert M, Kaufmann, Peter G, Knatterud, Genell L, Orleans, C Tracy, Spring, Bonnie, Trudeau, Kimberlee J, Whitlock, Evelyn P

“…The goal of evidence-based medicine is ultimately to improve patient outcomes and quality of care. Systematic reviews of the available published evidence are…”
Get full text

Thrombolytic Therapy vs Primary Percutaneous Coronary Intervention for Myocardial Infarction in Patients Presenting to Hospitals Without On-site Cardiac Surgery: A Randomized Controlled Trial by Aversano, Thomas, Aversano, Lynnet T, Passamani, Eugene, Knatterud, Genell L, Terrin, Michael L, Williams, David O, Forman, Sandra A, for the Atlantic Cardiovascular Patient Outcomes Research Team (C-PORT)

“…CONTEXT Trials comparing primary percutaneous coronary intervention (PCI) and thrombolytic therapy for treatment of acute myocardial infarction (MI) suggest…”
Get full text

Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function : The total occlusion study of Canada (TOSCA)-2 trial by DZAVIK, Vladimir, BULLER, Christopher E, THOMAS, Boban, BUSZMAN, Pawel, VOZZI, Carlos, GLANZ, Anthony, COHEN, Eric A, MECIAR, Peter, DEVLIN, Gerald, MASCETTE, Alice, SOPKO, George, KNATTERUD, Genell L, LAMAS, Gervasio A, HOCHMAN, Judith S, RANKIN, James M, MANCINI, G. B. John, CANTOR, Warren J, CARERE, Ronald J, ROSS, John R, ATCHISON, Deborah, FORMAN, Sandra

“…In the present study, we sought to determine whether opening a persistently occluded infarct-related artery (IRA) by percutaneous coronary intervention (PCI)…”
Get full text

Presenting characteristics as predictors of duration of treatment in sarcoidosis by BAUGHMAN, R. P, JUDSON, M. A, TEIRSTEIN, A, YEAGER, H, ROSSMAN, M, KNATTERUD, G. L, THOMPSON, B

“…Some sarcoidosis patients never need therapy, but many still require therapy more than 2 years after initial diagnosis. To determine what features at initial…”
Get full text

Associations of Mortality and Diabetes Complications in Patients With Type 1 and Type 2 Diabetes: Early Treatment Diabetic Retinopathy Study report no. 27 by Cusick, Michael, Meleth, Annal D, Agrón, Elvira, Fisher, Marion R, Reed, George F, Knatterud, Genell L, Barton, Franca B, Davis, Matthew D, Ferris, Frederick L, Chew, Emily Y

“…OBJECTIVE:--Diabetes is a leading cause of morbidity and mortality. The purpose of this study is to assess the associations between diabetes complications and…”
Get full text

The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly: Results from thrombolysis in myocardial infarction phase I, open label studies and the thrombolysis in myocardial infarction phase II pilot study by Chaitman, Bernard R., Thompson, Bruce, Wittry, Mark D., Stump, David, Hamilton, William P., David Hillis, L., Dwyer, James G., Solomon, Rachel E., Knatterud, Genell L.

“…The impact of age on hospital mortality, incidence of major hemorrhagic events and transfusion requirements was examined in 756 patients with acute myocardial…”
Get full text

Familial aggregation of sarcoidosis: A case-control etiologic study of sarcoidosis (ACCESS) by RYBICKI, Benjamin A, IANNUZZI, Michael C, DEPALO, Louis, HUNNINGHAKE, Gary, JOHNS, Carol, JUDSON, Marc A, KNATTERUD, Genell L, MCLENNAN, Geoffrey, NEWMAN, Lee S, RABIN, David L, ROSE, Cecile, TEIRSTEIN, Alvin S, FREDERICK, Margaret M, WEINBERGER, Steven E, YEAGER, Henry, CHERNIACK, Reuben, THOMPSON, Bruce W, ROSSMAN, Milton D, BRESNITZ, Eddy A, TERRIN, Michael L, MOLLER, David R, BARNARD, Juliana, BAUGHMAN, Robert P

“…Despite reports of familial clustering of sarcoidosis, little empirical evidence exists that disease risk in family members of sarcoidosis cases is greater…”
Get full text

Mechanisms of early death despite thrombolytic therapy: Experience from the Thrombolysis in Myocardial Infarction Phase II (TIMI II) study by Kielman, Neal S, Terrin, Michael, Mueller, Hiltrud, Chaitman, Bernard, Roberts, Robert, Knatterud, Genell L, Solomon, Rachel, McMahon, Robert P, Braunwald, Eugene

“…Mechanisms of death among patients who died within 18 h of enrollment in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) study were analyzed. Of…”
Get full text

Thrombolysis in Myocardial Infarction (TIMI) phase II trial: Outcome comparison of a “conservative strategy” in community versus tertiary hospitals by Feit, Frederick, Mueller, Hiltrud S, Braunwald, Eugene, Ross, Richard, Hodges, Morrison, Herman, Michael V, Knatterud, Genell L

“…In the conservative strategy arm of phase II of the Thrombolysis in Myocardial Infarction (TIMI) trial, 1,461 patients were treated with intravenous…”
Get full text

Mental stress-induced Ischemia and all-cause mortality in patients with coronary artery disease: Results from the Psychophysiological Investigations of Myocardial Ischemia study by SHEPS, David S, MCMAHON, Robert P, RACZYNSKI, James M, LIGHT, Kathleen, KRANTZ, David S, STONE, Peter H, KNATTERUD, Genell L, KAUFMANN, Peter G, BECKER, Lewis, CARNEY, Robert M, FREEDLAND, Kenneth E, COHEN, Jerome D, SHEFFIELD, David, GOLDBERG, A. David, KETTERER, Mark W, PEPINE, Carl J

“…Ischemia during laboratory mental stress tests has been linked to significantly higher rates of adverse cardiac events. Previous studies have not been designed…”
Get full text

Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18 by Davis, MD, Fisher, MR, Gangnon, RE, Barton, F, Aiello, LM, Chew, EY, Ferris, FL, 3rd, Knatterud, GL

“…To identify risk factors for the development of high-risk proliferative diabetic retinopathy (PDR) and for the development of severe visual loss or vitrectomy…”
Get full text

Long-term effects on Clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the Post Coronary Artery Bypass Graft Trial by KNATTERUD, G. L, ROSENBERG, Y, HOOGWERF, B. J, TERRIN, M. L, WHITE, C, CAMPEAU, L, GELLER, N. L, HUNNINGHAKE, D. B, FORMAN, S. A, FORRESTER, J. S, GOBEL, F. L, HERD, J. A, HICKEY, A

“…Background —The Post Coronary Artery Bypass Graft Trial, designed to compare the effects of 2 lipid-lowering regimens and low-dose anticoagulation versus…”
Get full text

Asymptomatic cardiac ischemia pilot (ACIP) study two-year follow-up : Outcomes of patients randomized to initial strategies of medical therapy versus revascularization by DAVIES, R. F, GOLDBERG, A. D, FORMAN, S, PEPINE, C. J, KNATTERUD, G. L, GELLER, N, SOPKO, G, PRATT, C, DEANFIELD, J, CONTI, C. R

“…Patients with ischemia during stress testing and ambulatory ECG monitoring have an increased risk of cardiac events, but it is not known whether their…”
Get full text